Global Apheresis Market

Apheresis Market Size, Share, Growth Analysis, By Product (Apheresis Disposals, Apheresis Devices), By Procedure (Plasmapheresis, Plateletpheresis), By Technology (Centrifugation, and Membrane Separation), By Application, By End user, By Region - Industry Forecast 2026-2033

Report ID: SQMIG35D2190 | Region: Global | Published Date: November, 2025
Pages: 157 |Tables: 92 |Figures: 76

To request a free sample copy of this report, please complete the form below.

Our Clients

  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt
  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt

    • FAQs

    Apheresis Market size was valued at USD 3.45 Billion in 2024 and is poised to grow from USD 3.83 Billion in 2025 to USD 8.92 Billion by 2033, growing at a CAGR of 11.15% during the forecast period (2026–2033).

    The market is moderately competitive, with a few major players dominating the industry. While the market has established a strong presence in many regions and demonstrated initial success, its full potential in developing regions is yet to be fully realized. The growth of the market is being propelled by increasing government initiatives and a rising awareness among people about the condition. This heightened awareness is driving the demand for advanced treatments and therapies in the market. 'Terumo BCT, Inc. (Japan) ', 'Fresenius Medical Care (Germany) ', 'Haemonetics Corporation (United States) ', 'Baxter International (United States) ', 'Asahi Kasei Medical Co., Ltd. (Japan) ', 'Kaneka Corporation (Japan) ', 'Cerus Corporation (United States) ', 'B. Braun Melsungen AG (Germany) ', 'Macopharma SA (France) ', 'Kawasumi Laboratories (Japan) ', 'Nikkiso Co., Ltd (Japan) ', 'Medica SPA (Italy) ', 'Miltenyi Biotec (Germany) ', 'Otsuka Holdings (JIMRO) (Japan) ', 'Cytosorbents Corporation (United States) ', 'Bioelettronica S.r.l. (Italy) ', 'Guangzhou Daji Medical (China) ', 'Beijing ZKSK Technology (China) ', 'Infomed SA (Switzerland) ', 'Haier Biomedical (China)'

    The rising incidence of chronic diseases such as cancer, autoimmune disorders, and cardiovascular diseases is driving the demand for apheresis procedures. Apheresis plays a crucial role in managing these conditions by selectively removing or collecting specific blood components, thereby improving patient outcomes.

    One key market trend in the apheresis market is the increasing adoption of personalized medicine and targeted therapies. As healthcare advancements continue to evolve, there is a growing emphasis on tailoring treatments to individual patients based on their specific medical conditions, genetic profiles, and treatment responses. This approach allows for precise and customized treatment regimens, optimizing therapeutic outcomes and improving patient care.

    The dominating region in the global apheresis market is North America. North America boasts a significant market share due to several factors. The region has a well-established healthcare infrastructure, advanced technological capabilities, and a high prevalence of chronic diseases that require apheresis procedures. Moreover, favorable reimbursement policies and strong awareness about the benefits of apheresis therapies contribute to the region's dominance. North America is home to key market players, cutting-edge research facilities, and a supportive regulatory framework, all of which further drive the market's growth in the region. These factors combined make North America the leading and dominating region in the global apheresis market.

    Related Reports

    Plasmapheresis Market
    Buy Now GET FREE SAMPLE
    Leukapheresis Market
    Buy Now GET FREE SAMPLE
    Plasma Therapy Market
    Buy Now GET FREE SAMPLE
    Orthobiologics Market
    Buy Now GET FREE SAMPLE
    Apoptosis Assay Market
    Buy Now GET FREE SAMPLE
    Hyperphosphatemia Therapeutics Market
    Buy Now GET FREE SAMPLE
    Biopreservation Market
    Buy Now GET FREE SAMPLE
    Electrophysiology Market
    Buy Now GET FREE SAMPLE

    Feedback From Our Clients

    Global Apheresis Market

    Report ID: SQMIG35D2190

    $5,300
    BUY NOW